EquitiesIndia.com

Healthcare · Specialty Chemicals

Acutaas Chemicals Ltd.

ACUTAAS

Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson's, antidepressant, and anticoagulant applications. It also provides specialty chemicals for use in battery chemicals, personal care, agrochemicals, coatings, electronics, and industrial processes; photoresist chemicals to semiconductor applications; electrolyte additives for lithium battery cells; and parabens, methyl salicylate, and other commodity chemicals for cosmetics, agrochemicals, and fine chemicals. The company was formerly known as Ami Organics Limited and changed its name to Acutaas Chemicals Limited in May 2025. Acutaas Chemicals Limited was founded in 2004 and is based in Surat, India.

Key metrics

Market Cap

₹19,340 cr

P/E Ratio

67.57x

P/B Ratio

14.77x

ROE

12.12%

ROCE

16.81%

Debt / Equity

0.01x

Net Margin

15.87%

Dividend Yield

6%

EPS

₹19.81

Period

FY2025

Shareholding pattern

As of Latest
Promoter: 37.58%FII: 26.60%Public: 35.82%

Deep-dive pages

Educational content — not investment adviceThis page presents publicly available information about Acutaas Chemicals Ltd. for educational purposes only. EquitiesIndia.com is not a SEBI-registered Investment Adviser or Research Analyst. Nothing here constitutes investment advice, a recommendation to buy or sell any security, or a solicitation to transact. All financial data shown is sourced from public BSE/NSE filings and is at least 90 days old. Past performance is not indicative of future results. Please consult a SEBI-registered adviser before making any investment decision.